Download the latest edition of Research Report by the Lymphoma Research Foundation. More >

LRF's in-person educational conferences include the National Educational Forum, Regional Lymphoma Workshops and local Ask the Doctor Programs. More >

The FDA approves the use of brentuximab vedotin (Adcetris) treatment of adult patients with primary cutaneous anaplastic large cell lymphoma (pcALCL) and CD30-expressing mycosis fungoides (MF). More >

1
2
3

Learn From Experts

The FocusOnPTCL.org website is designed to provide helpful information and resources to patients, caregivers, physicians, and others affected by peripheral T-cell lymphoma (PTCL).

We invite you to browse the site to learn more about PTCL.

Getting the Facts

Peripheral T-cell lymphoma (PTCL) comprises a group of rare and usually aggressive non-Hodgkin lymphomas (NHL) that develop from mature T-cells. Peripheral T-cell lymphoma represents a spectrum of T-cell lymphomas and accounts for approximately 10 percent to 15 percent of all NHL cases in the United States.

Recent Research

Recent research into peripheral T-cell lymphoma has led to significant advancements in the understanding and classification of the disease and its subtypes. Research continues on multiple fronts to develop better treatments for PTCL. We hope you will find the information presented here useful in understanding your disease and discussing it with your physician.

Ask the Doctor

LRF's Ask the Doctor About Lymphoma program is a national series of community based-programs which provide updates on lymphoma and new treatment options for patients.

Youtube